Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-025979·Larimar Therapeutics, Inc.
Schedule 13G ownership disclosure
LARIMAR THERAPEUTICS INC
Common Stock · CUSIP: 517125100
Event date: 2025-08-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Opaleye Management, Inc.
Shares: 4,110,000.00 · Class: 4.80%
- Opaleye, L.P.
Shares: 4,110,000.00 · Class: 4.80%
- James Silverman
Shares: 4,110,000.00 · Class: 4.80%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-025979
- Form type
- SCHEDULE 13G
- Filer
- Larimar Therapeutics, Inc.
- CIK
- CIK 1374690
- Filed
- Aug 29, 2025
- Reporting period
- Aug 29, 2025
- Description
- Schedule 13G beneficial ownership